Similarly, it has been demonstrated that oroxylin A reduces cognitive impairment brought on by the permanent blockage of bilateral common carotid arteries (2VO) by suppressing activated microglia and upregulating the expression of CREB and brain-derived neurotrophic factor (BDNF) [45]. The gene discussed is BDNF; the disease is Cognitive impairment.